205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.26%
Revenue growth 1.25-1.5x NXPI's 5.61%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
5.32%
Gross profit growth at 75-90% of NXPI's 5.91%. Bill Ackman would demand operational improvements to match competitor gains.
5.90%
EBIT growth 50-75% of NXPI's 8.02%. Martin Whitman would suspect suboptimal resource allocation.
6.24%
Operating income growth at 75-90% of NXPI's 8.02%. Bill Ackman would demand a plan to enhance operating leverage.
4.09%
Net income growth above 1.5x NXPI's 1.98%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
4.20%
EPS growth above 1.5x NXPI's 2.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
3.81%
Diluted EPS growth above 1.5x NXPI's 2.02%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.33%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.04%
Dividend growth under 50% of NXPI's 49.28%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-17.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-31.16%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
93.65%
10Y revenue/share CAGR at 50-75% of NXPI's 186.25%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
52.48%
5Y revenue/share CAGR at 50-75% of NXPI's 93.35%. Martin Whitman would worry about a lagging mid-term growth trajectory.
44.72%
3Y revenue/share CAGR at 50-75% of NXPI's 60.01%. Martin Whitman would question if the firm lags behind competitor innovations.
224.56%
10Y OCF/share CAGR 1.25-1.5x NXPI's 187.87%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
108.31%
5Y OCF/share CAGR at 75-90% of NXPI's 138.73%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
0.26%
3Y OCF/share CAGR under 50% of NXPI's 69.67%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
536.51%
Net income/share CAGR at 50-75% of NXPI's 803.88%. Martin Whitman might question if the firm’s product or cost base lags behind.
134.40%
Below 50% of NXPI's 1657.68%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
78.80%
Below 50% of NXPI's 1650.29%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
56.50%
Below 50% of NXPI's 547.90%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.19%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
69.13%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
573.58%
Dividend/share CAGR of 573.58% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.97%
Dividend/share CAGR of 129.97% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
49.53%
Below 50% of NXPI's 234.90%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
22.01%
AR growth well above NXPI's 7.68%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.75%
Inventory growth well above NXPI's 11.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.19%
Negative asset growth while NXPI invests at 5.71%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.86%
Under 50% of NXPI's 7.10%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.43%
We’re deleveraging while NXPI stands at 5.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.88%
R&D growth drastically higher vs. NXPI's 4.63%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
No Data
No Data available this quarter, please select a different quarter.